100% Quality Guarantee
PhD-Level Technical Support
Rat Collagen Type III Alpha 1 COL3a1 ELISA Kit
Key Features

Rat Collagen Type III Alpha 1 (COL3a1) ELISA Kit (RTDL00231)

SKU RTDL00231
Product Type ELISA Kit
Size 96 Assays
Uniprot P13941
Sensitivity 0.277ng/mL
Range 0.625-40ng/mL
ELISA Type Sandwich
Synonyms COL3-A1,COL3A1,EDS4A,Collagen Type III Alpha 1,Ehlers-Danlos Syndrome Type IV Autosomal Dominant,Collagen Alpha-1(III)chain
Reactivity Rat
Sample Type Serum, Plasma And Other Biological Fluids
€862

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Rat Collagen Type III Alpha 1 (COL3a1) ELISA Kit

The Rat Collagen Type III Alpha 1 (COL3A1) ELISA Kit is specifically designed for the precise measurement of COL3A1 levels in rat samples including serum, plasma, and tissue homogenates. With its high sensitivity and specificity, this kit ensures accurate and reproducible results, making it an invaluable tool for a variety of research studies.Collagen Type III Alpha 1 is a vital component of the extracellular matrix, playing a key role in tissue regeneration, wound healing, and structural support.

Abnormal levels of COL3A1 have been linked to various diseases and conditions such as fibrosis, cardiovascular diseases, and connective tissue disorders. Therefore, this ELISA kit provides researchers with essential information for studying these conditions and potentially identifying new therapeutic targets.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose